Display options
Share it on

Cancers (Basel). 2018 Nov 16;10(11). doi: 10.3390/cancers10110450.

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.

Cancers

Alberto Zanetto, Elena Campello, Luca Spiezia, Patrizia Burra, Paolo Simioni, Francesco Paolo Russo

Affiliations

  1. Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy. [email protected].
  2. Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padua University Hospital, 35128 Padua, Italy. [email protected].
  3. Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padua University Hospital, 35128 Padua, Italy. [email protected].
  4. Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy. [email protected].
  5. Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padua University Hospital, 35128 Padua, Italy. [email protected].
  6. Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, 35128 Padua, Italy. [email protected].

PMID: 30453547 PMCID: PMC6266984 DOI: 10.3390/cancers10110450

Abstract

It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein being the most frequent site (PVT). However, patients with HCC are peculiar as both cancer and liver cirrhosis are conditions that can perturb the hemostatic balance towards a prothrombotic state. Because HCC-related hypercoagulability is not clarified at all, the aim of the present review is to summarize the currently available knowledge on epidemiology and pathogenesis of non-malignant thrombotic complications in patients with liver cirrhosis and HCC. They are at increased risk to develop both PVT and non-splanchnic VTE, indicating that both local and systemic factors can foster the development of site-specific thrombosis. Recent studies have suggested multiple and often interrelated mechanisms through which HCC can tip the hemostatic balance of liver cirrhosis towards hypercoagulability. Described mechanisms include increased fibrinogen concentration/polymerization, thrombocytosis, and release of tissue factor-expressing extracellular vesicles. Currently, there are no specific guidelines on the use of thromboprophylaxis in this unique population. There is the urgent need of prospective studies assessing which patients have the highest prothrombotic profile and would therefore benefit from early thromboprophylaxis.

Keywords: cancer; hepatocellular carcinoma; hypercoagulability; portal vein thrombosis; venous thromboembolism

References

  1. Thromb Haemost. 2013 Aug;110(2):378-85 - PubMed
  2. J Hematol Oncol. 2015 Jul 10;8:83 - PubMed
  3. Am J Surg. 1970 Oct;120(4):527-30 - PubMed
  4. Hepatol Int. 2010 Jan 30;4(1):433-8 - PubMed
  5. Clin Gastroenterol Hepatol. 2016 Jan;14(1):124-31.e1 - PubMed
  6. Liver Int. 2015 Jan;35 Suppl 1:139-44 - PubMed
  7. AJR Am J Roentgenol. 2006 Mar;186(3):763-73 - PubMed
  8. Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):991-6 - PubMed
  9. Thromb J. 2011 Jan 18;9(1):1 - PubMed
  10. Hepatology. 1999 Jan;29(1):62-7 - PubMed
  11. Am J Gastroenterol. 2006 Jul;101(7):1524-8; quiz 1680 - PubMed
  12. Thromb Res. 2014 Dec;134(6):1220-3 - PubMed
  13. Intern Med J. 2018 Sep;48(9):1056-1063 - PubMed
  14. Ann Hepatol. 2012 Sep-Oct;11(5):686-90 - PubMed
  15. Tumour Biol. 2016 Nov;37(11):14391-14401 - PubMed
  16. Hepatol Res. 2012 Apr;42(4):433-4 - PubMed
  17. N Engl J Med. 2011 Jul 14;365(2):147-56 - PubMed
  18. World J Gastroenterol. 2018 Jul 21;24(27):2931-2948 - PubMed
  19. Dig Liver Dis. 2017 Apr;49(4):440-445 - PubMed
  20. Thromb Haemost. 2018 Feb;118(2):251-265 - PubMed
  21. J Cancer Res Clin Oncol. 2018 Nov;144(11):2085-2095 - PubMed
  22. J Cell Biol. 2013 Feb 18;200(4):373-83 - PubMed
  23. Blood. 2015 Sep 10;126(11):1379-89 - PubMed
  24. Hepatology. 2015 Feb;61(2):660-7 - PubMed
  25. Thromb Res. 2016 Jul;143:118-21 - PubMed
  26. Dig Dis Sci. 2011 Jul;56(7):2152-9 - PubMed
  27. Ther Drug Monit. 2015 Feb;37(1):40-4 - PubMed
  28. Vascul Pharmacol. 2011 Mar-Jun;54(3-6):59-67 - PubMed
  29. N Engl J Med. 1992 Oct 15;327(16):1128-33 - PubMed
  30. AJR Am J Roentgenol. 1993 Jun;160(6):1285-7 - PubMed
  31. Lancet Oncol. 2016 Oct;17(10):e452-e466 - PubMed
  32. Endoscopy. 2002 Jul;34(7):535-8 - PubMed
  33. J Exp Clin Cancer Res. 2016 Mar 25;35:54 - PubMed
  34. J Hepatol. 2016 Apr;64(4):834-42 - PubMed
  35. Anticancer Res. 2009 Jul;29(7):2531-4 - PubMed
  36. J Thromb Haemost. 2015 Jul;13(7):1245-53 - PubMed
  37. Thromb Res. 2015 Feb;135(2):292-7 - PubMed
  38. Medicine (Baltimore). 1999 Sep;78(5):285-91 - PubMed
  39. Fluids Barriers CNS. 2018 Jul 1;15(1):19 - PubMed
  40. Blood. 2013 Sep 5;122(10):1712-23 - PubMed
  41. Blood. 2008 May 15;111(10):4902-7 - PubMed
  42. Ann Surg Oncol. 2018 Oct;25(11):3214-3221 - PubMed
  43. Int J Biol Markers. 2014 Sep 30;29(3):e215-23 - PubMed
  44. J Hepatol. 2004 May;40(5):736-41 - PubMed
  45. Transplantation. 2012 Dec 15;94(11):1145-53 - PubMed
  46. Transplantation. 1994 Apr 27;57(8):1174-7 - PubMed
  47. J Clin Oncol. 2015 Feb 20;33(6):654-6 - PubMed
  48. Thromb Haemost. 2018 Jan;118(1):174-181 - PubMed
  49. Blood. 2017 Sep 28;130(13):1499-1506 - PubMed
  50. Pharmacotherapy. 2014 Oct;34(10):1043-9 - PubMed
  51. Thromb Haemost. 2018 May;118(S 01):S23-S33 - PubMed
  52. Chest. 2010 May;137(5):1145-9 - PubMed
  53. Cancer Invest. 2009;27 Suppl 1:63-74 - PubMed
  54. Clin Cancer Res. 2007 May 15;13(10):2870-5 - PubMed
  55. Ann Hepatol. 2013 Nov-Dec;12(6):952-8 - PubMed
  56. Surgery. 2014 Jan;155(1):134-44 - PubMed
  57. Leuk Lymphoma. 2006 Jun;47(6):1029-33 - PubMed
  58. Clin Gastroenterol Hepatol. 2010 Sep;8(9):800-5 - PubMed
  59. Chest. 2016 Feb;149(2):315-352 - PubMed
  60. Int J Hematol. 2001 Feb;73(2):137-44 - PubMed
  61. N Engl J Med. 2000 Dec 21;343(25):1846-50 - PubMed
  62. J Hepatol. 2017 Aug;67(2):282-292 - PubMed
  63. J Hepatol. 2016 Jan;64(1):179-202 - PubMed
  64. Thromb Haemost. 1997 Jul;78(1):126-32 - PubMed
  65. Clin Sci (Lond). 2000 Sep;99(3):207-14 - PubMed
  66. Gastroenterology. 1991 Jan;100(1):160-7 - PubMed
  67. Br J Cancer. 2005 Apr 25;92(8):1349-51 - PubMed
  68. J Med. 1975;6(1):61-4 - PubMed
  69. Gastroenterology. 2012 Nov;143(5):1253-1260.e4 - PubMed
  70. J Hepatol. 2009 Oct;51(4):682-9 - PubMed
  71. Br J Haematol. 2013 Dec;163(5):666-73 - PubMed
  72. Semin Thromb Hemost. 2014 Apr;40(3):277-83 - PubMed
  73. N Engl J Med. 2018 Feb 15;378(7):615-624 - PubMed
  74. J Clin Oncol. 2018 Jul 10;36(20):2017-2023 - PubMed
  75. J Thromb Haemost. 2008 Aug;6(8):1336-43 - PubMed
  76. Ann N Y Acad Sci. 2001;936:406-25 - PubMed
  77. Sci Rep. 2017 Jul 25;7(1):6438 - PubMed
  78. Cancer. 1995 Apr 15;75(8):2057-62 - PubMed
  79. Ann Pharmacother. 2013 Mar;47(3):333-9 - PubMed
  80. Oncology. 2013;85(5):269-77 - PubMed
  81. Cell Mol Neurobiol. 2016 Apr;36(3):301-12 - PubMed
  82. J Extracell Vesicles. 2015 Mar 13;4:26901 - PubMed
  83. Br J Cancer. 2010 Sep 28;103(7):947-53 - PubMed
  84. World J Gastroenterol. 2004 Sep 1;10(17):2472-7 - PubMed
  85. Gastroenterology. 2018 Oct 24;:null - PubMed
  86. Br J Cancer. 2007 Jan 29;96(2):290-5 - PubMed
  87. Liver Transpl. 2010 May;16(5):658-67 - PubMed
  88. Transpl Int. 2018 Dec;31(12):1318-1329 - PubMed
  89. Hepatology. 1992 Nov;16(5):1195-8 - PubMed
  90. Pharmacotherapy. 2013 Apr;33(4):375-82 - PubMed
  91. Lancet Oncol. 2004 Nov;5(11):655-63 - PubMed
  92. Semin Thromb Hemost. 2006 Oct;32(7):694-9 - PubMed
  93. Thromb Res. 2011 May;127(5):473-7 - PubMed
  94. Hepatology. 2003 Mar;37(3):520-7 - PubMed
  95. Thrombosis. 2013;2013:807526 - PubMed
  96. Rev Esp Enferm Dig. 2008 May;100(5):259-62 - PubMed
  97. Biomark Med. 2016 Jul;10(7):743-55 - PubMed
  98. Semin Thromb Hemost. 2015 Oct;41(7):756-64 - PubMed
  99. Am J Med. 1992 Feb;92(2):173-82 - PubMed
  100. Thromb Res. 2008;122(3):299-306 - PubMed
  101. J Gastrointestin Liver Dis. 2008 Sep;17(3):261-8 - PubMed
  102. Ann Surg. 2011 Feb;253(2):378-84 - PubMed
  103. Stem Cells. 1998;16(5):329-33 - PubMed
  104. Thromb Haemost. 2002 Apr;87(4):575-9 - PubMed
  105. AJR Am J Roentgenol. 1997 Mar;168(3):719-23 - PubMed
  106. JAMA. 2005 Feb 9;293(6):715-22 - PubMed
  107. J Clin Oncol. 2006 Jan 20;24(3):484-90 - PubMed
  108. Proteomics Clin Appl. 2017 Dec;11(11-12):null - PubMed
  109. Arch Intern Med. 2000 Mar 27;160(6):809-15 - PubMed
  110. Am J Gastroenterol. 2013 Apr;108(4):568-74 - PubMed
  111. J Gastrointest Cancer. 2018 Sep;49(3):275-282 - PubMed
  112. J Thromb Haemost. 2016 Jan;14(1):153-66 - PubMed
  113. Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4657-4662 - PubMed
  114. Ann Surg. 2001 Mar;233(3):379-84 - PubMed
  115. Am J Med. 2011 Jan;124(1):64-8 - PubMed
  116. Dig Dis Sci. 2008 Nov;53(11):3012-7 - PubMed
  117. Gut. 2005 May;54(5):691-7 - PubMed
  118. Arch Intern Med. 1964 Oct;114:497-500 - PubMed
  119. Clin Cancer Res. 2003 Nov 1;9(14):5339-45 - PubMed
  120. Semin Oncol. 2014 Jun;41(3):346-58 - PubMed
  121. Liver Int. 2014 Jan;34(1):26-32 - PubMed
  122. Thromb Haemost. 2018 Aug;118(8):1491-1506 - PubMed
  123. Eur J Gastroenterol Hepatol. 2015 May;27(5):585-92 - PubMed
  124. Hepatology. 2018 Oct;68(4):1347-1360 - PubMed
  125. Hepatology. 2018 Jan;67(1):358-380 - PubMed

Publication Types